CSP
2 min read
5

Conversion of shares in Electrolux Professional

December 30, 2024
0

Reading Time: < 1 minute According to the articles of association of Electrolux Professional AB (publ), owners of Series A shares are entitled to request that such shares are converted to Series B shares. Conversion reduces the total number of votes in the company. During

Continue Reading
CSP
1 min read
11

ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 30.12.2024

December 30, 2024
0

Reading Time: < 1 minute   ALEXANDRIA GROUP OYJ NOTIFICATION     30.12.2024 at 18:30 EET   ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 30.12.2024   Date 30.12.2024   Exchange transaction Buy   Share class ALEX   Amount 25   Average price/share 8.8500 EUR Highest

Continue Reading
CSP
1 min read
12

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 30.12.2024

December 30, 2024
0

Reading Time: < 1 minute Stock Exchange Release 30.12.2024 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 30.12.2024   Date 30.12.2024   Exchange transaction Buy   Share class FSKRS   Amount  819   Average price/share 14.6022 EUR Highest price/share 14.6600 EUR Lowest price/share

Continue Reading
CSP
2 min read
6

Buy-back of shares in MTG during week 52, 2024

December 30, 2024
0

Reading Time: 2 minutes During the period between 23 December and 27 December 2024 Modern Times Group MTG AB (publ) (LEI code 549300E8NDODRSX29339) (“MTG”) repurchased, in total, 34,649 own class B shares (ISIN code SE0018012494) under the share repurchase program initiated by the Board of Directors.

Continue Reading
CSP
7 min read
6

Notice to the Extraordinary General Meeting of Eevia Health Abp

December 30, 2024
0

Reading Time: 5 minutes Notice is given to the shareholders of Eevia Health Abp (Plc) to the Extraordinary General Meeting to be held on 17 January 2025 at 12:00 (Finnish time GMT +3) at the main office of Eevia Health Abp in Koulukatu 14, Seinäjoki, Finland.

Continue Reading
CSP
1 min read
9

Calligo publishes its monthly management accounts for November 2024

December 30, 2024
0

Reading Time: < 1 minute The Company has today, the 30th of December 2024, published its November 2024 unaudited consolidated monthly management accounts for the Calligo group, which can be viewed on the Company’s website. Brendan Walsh, Company Secretary & General Counsel

Continue Reading
CSP
3 min read
9

Dataloy Caps Off 2024 with Record Growth and Q4 Innovations Driving Maritime Excellence

December 30, 2024
0

Reading Time: 2 minutes Closing 2024 with close to 25% revenue growth, including a strong fourth quarter, Dataloy Systems continues to strengthen its position in maritime digitalisation. Bergen, Norway – 30 December 2024 – Dataloy Systems, a global leader in voyage management solutions, concludes 2024 on

Continue Reading
BC.GAME Launches Wukong Slot Game Inspired by the AAA Hit
CSP
2 min read
44

BC.GAME Launches Wukong Slot Game Inspired by the AAA Hit

December 30, 2024
0

Reading Time: 2 minutes BC.GAME has launched its latest slot game, Wukong, inspired by the acclaimed Black Myth: Wukong. Officially released on December 24, this 6-reel, 5-row slot game allows players to immerse themselves in Wukong’s legendary journey, with the chance to win rewards of up

Continue Reading
Scandinavian ChemoTech Splits Business Units to Boost Cash Flow and will suggest a new name for the group
CSP
3 min read
10

Scandinavian ChemoTech Splits Business Units to Boost Cash Flow and will suggest a new name for the group

December 30, 2024
0

Reading Time: 3 minutes Since 2021, Scandinavian ChemoTech has operated two distinct business units – Human Care and Animal Care. While Human Care was the group’s initial focus, the Board of Directors has made key decisions to support the independence and growth of the two separate

Continue Reading
Immedica to acquire biopharmaceutical company Marinus Pharmaceuticals, Inc.
CSP
11 min read
9

Immedica to acquire biopharmaceutical company Marinus Pharmaceuticals, Inc.

December 30, 2024
0

Reading Time: 7 minutes Stockholm, Sweden and Radnor, Pa. – December 30, 2024 – Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc. (Nasdaq:  MRNS), a pharmaceutical company committed to improving the lives of patients with seizure disorders, today

Continue Reading